Assessing the Quality of Pharmacoeconomic Studies in India Pooja R. DesaiHitesh S. ChandwaniKaren L. Rascati Systematic Review 27 December 2012 Pages: 749 - 762
Cost of Illness of Cystic Fibrosis in Germany Mareike HeimeshoffHelge HollmeyerDoris Staab Original Research Article 27 December 2012 Pages: 763 - 777
Reimbursement Decisions of the All Wales Medicines Strategy Group Warren G. LinleyDyfrig A. Hughes Original Research Article 27 December 2012 Pages: 779 - 794
Lost Productivity in Four European Countries among Patients with Rheumatic Disorders Saskia KniesMath J. J. M. CandelJohan L. Severens Original Research Article 27 December 2012 Pages: 795 - 807
Costs Associated with Febrile Neutropenia in the US Shannon L. MichelsRich L. BarronGary H. Lyman Original Research Article 27 December 2012 Pages: 809 - 823
A Lifetime Markov Model for the Economic Evaluation of Chronic Obstructive Pulmonary Disease Petra MennReiner LeidlRolf Holle Original Research Article 27 December 2012 Pages: 825 - 840
Dabigatran Etexilate Kate McKeage Adis Pharmacoeconomic Drug Evaluation 27 December 2012 Pages: 841 - 855
Caregivers’ Quality of Life and Economic Evaluations Afschin Gandjour Correspondence 27 December 2012 Pages: 857 - 858
The Authors’ Reply Hareth Al-JanabiTerry N. FlynnJoanna Coast Correspondence 27 December 2012 Pages: 858 - 858